Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study.
Kamlesh Khunti F MedSciChristin L HertzLise Lotte N HusemoenEmina MocevicRikke B NordsborgJohanne S PiltoftStephen C BainPublished in: Diabetic medicine : a journal of the British Diabetic Association (2021)
These analyses provide important information to identify people who may benefit from primary prevention of cardiovascular disease. Modifiable cardiovascular risk factors should be controlled early in all individuals with type 2 diabetes (as well as in all individuals with cardiovascular disease).